Matches in SemOpenAlex for { <https://semopenalex.org/work/W2322582875> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2322582875 abstract "Abstract #5036 Background: Estrogen stimulates breast tissue to increase cell divisions (mitosis) and is implicated in breast cancer progression. ER action is complex and requires functional interactions with coregulators. Proline-, glutamic acid-, and leucine-rich protein (PELP)-1, also known as modulator of nongenomic actions of estrogen receptor (MNAR), is a novel nuclear receptor (ER) coregulator with multitude of functions. Emerging evidence suggest that PELP1 expression is deregulated in breast cancer and serves as a scaffolding protein that couples various signaling complexes with estrogen receptor. In this study we found that ER coregulator PELP1 plays a novel role in mitosis. Material and Methods: To understand the mechanism by which ER coregulator PELP1 contribute to breast cancer progression, we have utilized small RNA interference methodology and established breast cancer model cells that stably express PELP1-shRNA (MCF7-PELP1shRNA). FACS analysis was used to determine the cell cycle status of the model cells. Using confocal microscopy, immunoprecipitation, in vitro kinase assays, site directed mutagenesis and Western analysis using phospho-antibodies we studied the mechanism and significance of PELP1 signaling in mitotic progression. We also developed PELP1 siRNA nanoparticles and used them as well as CDK1 inhibitors in cell proliferation studies. Results: Down regulation of PELP1 expression resulted in decreased estrogen mediated cell proliferation, delayed mitotic progression and induced accumulation of mitotic cells. Interestingly, PELP1 depleted cells also exhibited multinucleation. Western analysis of various markers of mitotic progression revealed a delay in the kinetics of G2M initiation and progression. Confocal analysis revealed colocalization of CDK1 and PELP1 in G2M. Immunoprecipitation assays demonstrate that endogenous CDK1 form functional complex with PELP1 and Src kinase during mitosis. Using deletion and mutagenesis approach, we have mapped the putative CDK1 phosphorylation sites on PELP1. Down regulation of PELP1 or overexpression of PELP1 mutants (that cannot be phosphorylated by CDK1), reduces the magnitude of Src activation, which is an essential driving force for timely progression of M phase. PELP1 siRNA nanoparticles alone or in combination with CDK1 inhibitors have shown to significantly reduce the proliferation of breast cancer cells and showed increased response in tamoxifen resistant breast cancer cells. Discussion: These results suggest that ER coregulator PELP1 play a novel role in G2M progression. Since PELP1 expression is deregulated in breast cancer, PELP1 ability to regulate mitosis could contribute to the progression of cancer by causing genomic instability through the deregulation of mitosis. Taken together our findings suggest that estrogen can promote neoplasia using coregulators by two distinct mechanisms (1) Coregulator induction of target genes and (2) Coregulator mediated actions in mitosis. ER coregulator PELP1 play multiple roles in Estrogen mediated neoplasia, and thus represent a target for novel therapeutic breast cancer strategies by forming the “next generation” of antimitotic drugs. Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 5036." @default.
- W2322582875 created "2016-06-24" @default.
- W2322582875 creator A5032399269 @default.
- W2322582875 creator A5045482923 @default.
- W2322582875 creator A5052705432 @default.
- W2322582875 creator A5053377661 @default.
- W2322582875 creator A5083785629 @default.
- W2322582875 date "2009-01-15" @default.
- W2322582875 modified "2023-09-25" @default.
- W2322582875 title "Potential role of estrogen receptor coregulator in mitosis." @default.
- W2322582875 doi "https://doi.org/10.1158/0008-5472.sabcs-5036" @default.
- W2322582875 hasPublicationYear "2009" @default.
- W2322582875 type Work @default.
- W2322582875 sameAs 2322582875 @default.
- W2322582875 citedByCount "2" @default.
- W2322582875 crossrefType "proceedings-article" @default.
- W2322582875 hasAuthorship W2322582875A5032399269 @default.
- W2322582875 hasAuthorship W2322582875A5045482923 @default.
- W2322582875 hasAuthorship W2322582875A5052705432 @default.
- W2322582875 hasAuthorship W2322582875A5053377661 @default.
- W2322582875 hasAuthorship W2322582875A5083785629 @default.
- W2322582875 hasConcept C120504264 @default.
- W2322582875 hasConcept C121608353 @default.
- W2322582875 hasConcept C134018914 @default.
- W2322582875 hasConcept C1491633281 @default.
- W2322582875 hasConcept C172313692 @default.
- W2322582875 hasConcept C2777164284 @default.
- W2322582875 hasConcept C29537977 @default.
- W2322582875 hasConcept C502942594 @default.
- W2322582875 hasConcept C530470458 @default.
- W2322582875 hasConcept C54355233 @default.
- W2322582875 hasConcept C55493867 @default.
- W2322582875 hasConcept C62112901 @default.
- W2322582875 hasConcept C84606932 @default.
- W2322582875 hasConcept C86803240 @default.
- W2322582875 hasConcept C93304396 @default.
- W2322582875 hasConcept C95444343 @default.
- W2322582875 hasConcept C96307122 @default.
- W2322582875 hasConceptScore W2322582875C120504264 @default.
- W2322582875 hasConceptScore W2322582875C121608353 @default.
- W2322582875 hasConceptScore W2322582875C134018914 @default.
- W2322582875 hasConceptScore W2322582875C1491633281 @default.
- W2322582875 hasConceptScore W2322582875C172313692 @default.
- W2322582875 hasConceptScore W2322582875C2777164284 @default.
- W2322582875 hasConceptScore W2322582875C29537977 @default.
- W2322582875 hasConceptScore W2322582875C502942594 @default.
- W2322582875 hasConceptScore W2322582875C530470458 @default.
- W2322582875 hasConceptScore W2322582875C54355233 @default.
- W2322582875 hasConceptScore W2322582875C55493867 @default.
- W2322582875 hasConceptScore W2322582875C62112901 @default.
- W2322582875 hasConceptScore W2322582875C84606932 @default.
- W2322582875 hasConceptScore W2322582875C86803240 @default.
- W2322582875 hasConceptScore W2322582875C93304396 @default.
- W2322582875 hasConceptScore W2322582875C95444343 @default.
- W2322582875 hasConceptScore W2322582875C96307122 @default.
- W2322582875 hasLocation W23225828751 @default.
- W2322582875 hasOpenAccess W2322582875 @default.
- W2322582875 hasPrimaryLocation W23225828751 @default.
- W2322582875 hasRelatedWork W1569625861 @default.
- W2322582875 hasRelatedWork W2001738003 @default.
- W2322582875 hasRelatedWork W2013074747 @default.
- W2322582875 hasRelatedWork W2038486904 @default.
- W2322582875 hasRelatedWork W2044492477 @default.
- W2322582875 hasRelatedWork W2055495157 @default.
- W2322582875 hasRelatedWork W2060720567 @default.
- W2322582875 hasRelatedWork W2062542032 @default.
- W2322582875 hasRelatedWork W2072343646 @default.
- W2322582875 hasRelatedWork W2072613049 @default.
- W2322582875 hasRelatedWork W2081626490 @default.
- W2322582875 hasRelatedWork W2086117273 @default.
- W2322582875 hasRelatedWork W2129309277 @default.
- W2322582875 hasRelatedWork W2141289004 @default.
- W2322582875 hasRelatedWork W2141312827 @default.
- W2322582875 hasRelatedWork W2154425566 @default.
- W2322582875 hasRelatedWork W2155871333 @default.
- W2322582875 hasRelatedWork W2300860717 @default.
- W2322582875 hasRelatedWork W2727162911 @default.
- W2322582875 hasRelatedWork W3109568790 @default.
- W2322582875 isParatext "false" @default.
- W2322582875 isRetracted "false" @default.
- W2322582875 magId "2322582875" @default.
- W2322582875 workType "article" @default.